Physical Activity in Bronchiectasis

NCT01569009 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2013-07-25

No results posted yet for this study

Summary

The primary aim of this study is to examine the physical activity levels of patients with bronchiectasis.

Subsidiary aims are:

1. To examine whether there is a relationship between the physical activity levels of patients with bronchiectasis and clinical phenotype (disease severity, exercise capacity, quality of life or other symptoms of their disease). The investigators also want to explore the relationship between physical activity levels and readiness to change physical activity behaviour (stages of change, self-efficacy, decisional balance and processes of change).
2. To assess the feasibility and acceptability of the physical activity assessment tools: ActiGraph, ActivPAL, pedometer and the International Physical Activity Questionnaire.

Hypothesis:

Patients with bronchiectasis will have low levels of physical activity, and this is related to their clinical phenotype (disease severity, exercise capacity, quality of life and other symptoms of their disease) and also their readiness to change physical activity behaviour (stages of change, self-efficacy, processes of change and decisional balance).

Conditions

Sponsors & Collaborators

  • Belfast Health and Social Care Trust

    collaborator OTHER
  • Western Health and Social Care Trust

    collaborator OTHER
  • Southern Health and Social Care Trust

    collaborator OTHER_GOV
  • Queen's University, Belfast

    collaborator OTHER
  • University of Strathclyde

    collaborator OTHER
  • University of Ulster

    lead OTHER

Principal Investigators

  • Judy M Bradley, PhD · University of Ulster

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01569009 on ClinicalTrials.gov